Esperion Therapeutics Inc Working Capital to Net Assets Ratio
Esperion Therapeutics Inc working capital to net assets ratio. Esperion Therapeutics Inc (ESPR) has a Working Capital to Net Assets ratio of -0.3% as of September 2025. Working capital of $1.43 Million (current assets of $360.46 Million minus current liabilities of $359.03 Million) is measured against net assets of $-451.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Esperion Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Esperion Therapeutics Inc (1999–2024)
Working capital to net assets ratio of Esperion Therapeutics Inc from 1999 to 2024. This chart shows how Esperion Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 1999 to 2024. As of September 2025, the ratio stands at -0.3%, reflecting working capital of $1.43 Million against net assets of $-451.36 Million USD. See ESPR defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Esperion Therapeutics Inc Working Capital to Net Assets Ratio by Year (1999–2024)
Esperion Therapeutics Inc working capital to net assets ratio by year from 1999 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Esperion Therapeutics Inc from 1999 to 2024, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Esperion Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -23.6% | $91.77 Million | $-388.72 Million | $338.00 Million | $246.23 Million | ▼ -13.8 pp |
| 2023 | -9.9% | $44.84 Million | $-454.99 Million | $201.06 Million | $156.22 Million | ▲ +37.8 pp |
| 2022 | -47.7% | $154.38 Million | $-323.78 Million | $246.68 Million | $92.31 Million | ▲ +82.1 pp |
| 2021 | -129.8% | $255.62 Million | $-196.94 Million | $328.97 Million | $73.35 Million | ▲ +132.2 pp |
| 2020 | -262.0% | $251.83 Million | $-96.13 Million | $345.90 Million | $94.07 Million | ▼ -991.9 pp |
| 2019 | 730.0% | $145.63 Million | $19.95 Million | $211.71 Million | $66.08 Million | ▲ +631.0 pp |
| 2018 | 99.0% | $78.30 Million | $79.12 Million | $142.63 Million | $64.33 Million | ▲ +29.2 pp |
| 2017 | 69.8% | $170.78 Million | $244.69 Million | $203.92 Million | $33.14 Million | ▼ -16.8 pp |
| 2016 | 86.6% | $197.99 Million | $228.60 Million | $213.58 Million | $15.59 Million | ▲ +13.9 pp |
| 2015 | 72.7% | $208.77 Million | $287.26 Million | $214.39 Million | $5.62 Million | ▼ -3.2 pp |
| 2014 | 75.8% | $101.28 Million | $133.55 Million | $106.77 Million | $5.49 Million | ▼ -0.3 pp |
| 2013 | 76.1% | $56.42 Million | $74.09 Million | $60.62 Million | $4.20 Million | ▲ +18.4 pp |
| 2012 | 57.7% | $-10.03 Million | $-17.39 Million | $7.14 Million | $17.17 Million | ▲ +66.4 pp |
| 2011 | -8.7% | $524.82K | $-6.06 Million | $1.86 Million | $1.34 Million | ▼ -112.8 pp |
| 2002 | 104.1% | $40.33 Million | $38.74 Million | $45.26 Million | $4.93 Million | ▲ +6.5 pp |
| 2001 | 97.6% | $64.93 Million | $66.50 Million | $71.29 Million | $6.36 Million | ▲ +2.8 pp |
| 2000 | 94.8% | $64.18 Million | $67.69 Million | $71.34 Million | $7.16 Million | ▼ -16.8 pp |
| 1999 | 111.6% | $3.14 Million | $2.81 Million | $6.04 Million | $2.90 Million | — |